mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.004 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
Bortezomib |
FIMM |
pan-cancer |
AAC |
-0.4 |
0.004 |
mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.005 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.005 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.006 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.006 |